The «Medsintez» plant took part in the exhibition of achievements of the domestic pharmaceutical and medical industry held as part of the state program named 'Pharmaceutical and Medical Industry Development for 2013-2020' in Moscow.

The event was held from June 13 to 16 in the State Duma building. The organizers, the State Duma and the Ministry of Industry and Trade of the Russian Federation, timed the exhibition to the Medical Specialist Day, which is traditionally celebrated on the third Sunday of June.

The exposition of the Ministry of Industry and Trade brought together more than 30 big Russian companies operating in the medical and pharmaceutical industries. Deputies of all factions, representatives of ministries and departments, experts and doctors were demonstrated the cutting-edge equipment, modern medicines recently developed by our biologists and rehabilitation know-how. Medsintez was among those who represented the Ural region at the exhibition.

“Great Uralians! They produce a lot for the domestic market,” pointed out an exhibition guest upon the examination of our plant's stand, where finished dosage forms of Rosinsulin, human genetically engineered insulin, a sample of our proprietary, domestic substance, which currently undergoes clinical trials, and Triazavirin, the latest antiviral remedy, were presented. An exhibition sample package of Triazavirin attracted special attention.

 

“What is this new antiviral remedy? Is it already available in pharmacies? ” many people asked. Triazavirin, an original Russian drug, is a direct-acting formulation effective against 15 types of influenza, including the A/H1N1 virus (swine flu) and H5N1 (bird flu). Triazavirin is active against resistant forms of viruses and features proven safety.

Some drugs urge the immune system to make the body fight against a disease on its own, while others only eliminate or reduce symptoms like a headache or a runny nose, but the pathogen remains in the body. As for etiotropic drugs, including Triazavirin, they affect a virus directly, thus removing a cause of the disease rather than its manifestations.

As of January 1, 2017, as part of the Pharmaceutical and Medical Industry Development for 2013-2020 state program, 44 import-substituting drugs were developed and marketed, including Triazavirin. The Russian pharmaceutical industry's production volumes increased over January-March 2017 by 13.8% compared to January-March 2016 and amounted to almost 67 billion roubles.

On June 14, the official opening day of the exhibition, the exposition was visited by Alexander Zhukov, First Deputy Chairman of the State Duma of the Russian Federation, Irina Yarovaya, Deputy Chairman of the State Duma of the Russian Federation, and Sergey Tsyb, Deputy Minister of Industry and Trade of the Russian Federation.

As part of the exhibition, on June 15, a roundtable discussion on the topic 'Improvement of the Legislation in the Field of State Regulation of Medical Device Circulation in the Russian Federation' took place in the State Duma. According to the official State Duma website (www.duma.gov.ru), at the opening of the discussion, Chairman of the Health Care Committee Dmitry Morozov pointed out that the domestic medical industry has made a big step forward, but manufacturers still need special attention and support from the state.

In the field of medical device circulation, more than 20 regulations are in force, which often contradict each other. There are no unified terminology and clear criteria for admitting a medical device to use. The medical device classification, methods of testing, registration and quality control are questionable. The discussion participants came to the conclusion that a separate law is required to regulate this strategically important industry. They recommended the Government to develop an appropriate document, align the existing regulatory framework with the requirements of the Eurasian Economic Union and consider reducing the timeframes for registering and tendering procedures when it comes to medical device procurement. According to www.duma.gov.ru, the Ministry of Health was offered to determine a medical device interchangeability routine, while regional executive authorities had to create conditions for import substitution.

Dmitry Morozov, Chairman of the State Duma Committee on Health Care, handed certificates to all exhibitors.

“What you have demonstrated, dear colleagues,” began his speech Dmitry Morozov, “has plunged us into an atmosphere of pride, on the one hand, and, on the other hand, into an atmosphere of great responsibility. Now, we realize what you expect from us, what to focus on. It's a big benefit. This is not just an exhibition but strengthening of good in the minds of so many deputies, who are often far from healthcare, far from understanding the reality and sometimes immersed in criticism and the media. I know the problems your enterprises face. In such difficult conditions, you generate amazing results,” said Chairman of the Committee.